Literature DB >> 31227960

Investigating the effects of glaucomatous damage on the multifocal visual evoked potential parameters.

Amir Danyaei1, Ali Kasiri2, Seyed Mahmoud Latifi3, Parvin Armiun4, Mohammad Javad Tahmasebi1.   

Abstract

PURPOSE: To investigate the effects of glaucomatous damage on the mfVEP parameters of patients suffering from primary open-angle glaucoma (POAG).
METHODS: Fifteen healthy subjects and 15 patients with unilateral POAG participated in this study. In addition, routine ophthalmological examinations including visual acuity, anterior segment examination, posterior segment examination, intraocular pressure, mfVEP with electrophysiological system, RETI-port/Scan 21, and visual field test with automated Humphrey ZEISS HFA II 750i Perimeter were also performed.
RESULTS: The results show that there was a strong correlation between the ∆MDs and the number of abnormal points with the ∆amplitudes more than 256 nV, in patients (n = 15, r = 0.802, p < 0.05), but no correlations were found between the mean sensitivity differences (ΔPSDs) and mfVEP parameters.
CONCLUSIONS: Comparing the monocular mfVEP responses from both eyes is an appropriate method to detect unilateral damage. Achievement of more development and making the mfVEP test more functional can be a solution for early diagnosis in most of the eye diseases.

Entities:  

Keywords:  Mean deviation; Multifocal visual evoked potential; Pattern standard deviation; Visual field

Mesh:

Year:  2019        PMID: 31227960     DOI: 10.1007/s10792-019-01138-0

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  11 in total

1.  Multifocal ERG and VEP responses and visual fields: comparing disease-related changes.

Authors:  D C Hood; X Zhang
Journal:  Doc Ophthalmol       Date:  2000       Impact factor: 2.379

2.  OBJECTIVE VISUAL FIELD TESTING. OCCIPITAL POTENTIALS EVOKED FROM SMALL VISUAL STIMULI.

Authors:  R M COPENHAVER; G D BEINHOCKER
Journal:  JAMA       Date:  1963-11-23       Impact factor: 56.272

3.  The multifocal visual evoked potential: an objective measure of visual fields?

Authors:  William Seiple; Karen Holopigian; Colleen Clemens; Vivienne C Greenstein; Donald C Hood
Journal:  Vision Res       Date:  2004-12-19       Impact factor: 1.886

4.  Visual field defects and multifocal visual evoked potentials: evidence of a linear relationship.

Authors:  Donald C Hood; Vivienne C Greenstein; Jeffrey G Odel; Xian Zhang; Robert Ritch; Jeffrey M Liebmann; Jenny E Hong; Candice S Chen; Phamornsak Thienprasiddhi
Journal:  Arch Ophthalmol       Date:  2002-12

5.  Comparison of cathode ray tube and liquid crystal display stimulators for use in multifocal VEP.

Authors:  Marÿke Fox; Colin Barber; David Keating; Alan Perkins
Journal:  Doc Ophthalmol       Date:  2014-07-02       Impact factor: 2.379

6.  Correlation of pattern reversal visual evoked potential parameters with the pattern standard deviation in primary open angle glaucoma.

Authors:  Ruchi Kothari; Pradeep Bokariya; Ramji Singh; Smita Singh; Purvasha Narang
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

7.  Clinical application of the multifocal VEPs.

Authors:  Y Betsuin; Y Mashima; H Ohde; R Inoue; Y Oguchi
Journal:  Curr Eye Res       Date:  2001-01       Impact factor: 2.424

8.  Tracking the recovery of local optic nerve function after optic neuritis: a multifocal VEP study.

Authors:  D C Hood; J G Odel; X Zhang
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-11       Impact factor: 4.799

9.  The effects of glaucoma on the latency of the multifocal visual evoked potential.

Authors:  C Rodarte; D C Hood; E B Yang; T Grippo; V C Greenstein; J M Liebmann; R Ritch
Journal:  Br J Ophthalmol       Date:  2006-05-17       Impact factor: 4.638

10.  Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma.

Authors:  Vincenzo Parisi; Stefano Miglior; Gianluca Manni; Marco Centofanti; Massimo G Bucci
Journal:  Ophthalmology       Date:  2006-01-10       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.